Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tighter Controls, Flood Of Orders Force Chinese Medical Suppliers To Say 'No' To The World

Executive Summary

As global buyers rush to order protective face masks, testing kits and ventilators from China, the world's largest medical supplies producer, some manufacturers are refusing to take the orders.

You may also be interested in...



China Coronavirus Approvals: Fast, Free And Fine?

A lack of Emergency Use Authorization potentially jeopardizes China’s efforts to fight the deadly virus outbreak, says a regulatory veteran.

'No Second China': EU Firms Face Coronavirus Fallout

The general economic and business impact on European firms from the coronavirus in China is widespread and severe, and companies must consider diversifying, warns an influential European trade group in a just-released business survey. But it concedes there are no China alternatives.

Innovation-Friendly? Cases Indicate How Far China's Willing To Protect Patents

Increasingly looking to China to commercialize their latest therapies, multinationals may be leaping into unknown waters to navigate an intellectual property judiciary and administrative maze, in a country where some copy drugs have been approved before patent expiry. With a government trying to balance innovation and access, two recent rulings involving AstraZeneca shed rare light onto China’s protections for innovation, with advisors pointing to challenges and success factors.

Topics

Related Companies

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel